Keiichi Fukuda is the founder of Heartseed. Heartseed has raised $74M in total funding. Latest round: Series D. Based in Tokyo, Japan.
Keiichi Fukuda is the co-founder and CEO of Heartseed, a Tokyo-based biotechnology company developing iPSC-derived cardiomyocytes for the treatment of heart failure. Founded in 2015, the company has raised approximately $74 million in total funding as of May 2023. Fukuda has 20 years of experience in cardiac regenerative medicine research and is also a Professor at the Department of Cardiology, Keio University, Tokyo. Heartseed's lead pipeline, HS-001, is an iPSC-derived regenerative medicine for heart failure.
Full founder directory · Investor directory · Company funding database · Fundraising library